Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes
Objective To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation. Me...
Saved in:
Published in | Arthritis & rheumatology (Hoboken, N.J.) Vol. 63; no. 5; pp. 1459 - 1464 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.05.2011
Wiley Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective
To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation.
Methods
NLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF‐κB activation.
Results
A heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide‐binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF‐κB activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12‐associated disorders (NLRP12AD).
Conclusion
Given the rarity of known NLRP12‐associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. |
---|---|
AbstractList | Objective
To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation.
Methods
NLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF‐κB activation.
Results
A heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide‐binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF‐κB activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12‐associated disorders (NLRP12AD).
Conclusion
Given the rarity of known NLRP12‐associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation. NLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF-κB activation. A heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide-binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF-κB activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12-associated disorders (NLRP12AD). Given the rarity of known NLRP12-associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. Objective: To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation.Methods: NLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF-κB activation.Results: A heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide-binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF-κB activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12-associated disorders (NLRP12AD).Conclusion: Given the rarity of known NLRP12-associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. OBJECTIVETo gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation.METHODSNLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF-κB activation.RESULTSA heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide-binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF-κB activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12-associated disorders (NLRP12AD).CONCLUSIONGiven the rarity of known NLRP12-associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. Objective To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation. Methods NLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF-[kappa]B activation. Results A heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide-binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF-[kappa]B activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12-associated disorders (NLRP12AD). Conclusion Given the rarity of known NLRP12-associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. [PUBLICATION ABSTRACT] Objective To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a splice site mutation have so far been identified, and to assess the functional consequences of the identified missense variation. Methods NLRP12 was screened for mutations by direct sequencing. Functional assays were performed in HEK 293T cells stably expressing the proapoptotic protein ASC and procaspase 1, in order to determine the effects of normal and mutated NLRP12 proteins on speck formation, caspase 1 signaling, and NF- Delta *kB activation. Results A heterozygous NLRP12 missense mutation involving a CpG site (c.1054C>T; p.Arg352Cys) was identified in exon 3, which encodes the nucleotide-binding site (NBS) of the protein, in 2 patients from different countries and carrying different NLRP12 haplotypes. The mutation, which does not alter the inhibitory effect of NLRP12 on NF- Delta *kB activation, increases speck formation and activates caspase 1 signaling. To define this new class of PFS, we propose the term NLRP12-associated disorders (NLRP12AD). Conclusion Given the rarity of known NLRP12-associated disorders, the identification of this NLRP12 molecular defect contributes to the delineation of the clinical spectrum associated with mutations in this gene and highlights the importance of screening NLRP12 in patients presenting with unexplained PFS. This study also demonstrates, by means of functional assays, the deleterious effect of this recurrent missense mutation; the gain of function for speck formation and caspase 1 signaling associated with this NBS mutation is consistent with the inflammatory phenotype of PFS. |
Author | Morali, Alain Le Borgne, Gaëlle Duquesnoy, Philippe Cochet, Emmanuelle Jéru, Isabelle Sarkisian, Tamara Hayrapetyan, Hasmik Grateau, Gilles Amselem, Serge |
Author_xml | – sequence: 1 givenname: Isabelle surname: Jéru fullname: Jéru, Isabelle – sequence: 2 givenname: Gaëlle surname: Le Borgne fullname: Le Borgne, Gaëlle – sequence: 3 givenname: Emmanuelle surname: Cochet fullname: Cochet, Emmanuelle – sequence: 4 givenname: Hasmik surname: Hayrapetyan fullname: Hayrapetyan, Hasmik – sequence: 5 givenname: Philippe surname: Duquesnoy fullname: Duquesnoy, Philippe – sequence: 6 givenname: Gilles surname: Grateau fullname: Grateau, Gilles – sequence: 7 givenname: Alain surname: Morali fullname: Morali, Alain – sequence: 8 givenname: Tamara surname: Sarkisian fullname: Sarkisian, Tamara – sequence: 9 givenname: Serge surname: Amselem fullname: Amselem, Serge email: serge.amselem@trs.aphp.fr |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24218763$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21538323$$D View this record in MEDLINE/PubMed https://inserm.hal.science/inserm-03889764$$DView record in HAL |
BookMark | eNp90V9rFDEQAPAgFXutPvgFJCCigttmks0m93iU1hYOlVKfQzY7iym7yZncVu7bm3PPCoI-hSG_zJ_MCTkKMSAhL4GdAWP83KbtmWC8hidkAZIvKwYCjsiCMVZXQi7hmJzkfF9CLqR4Ro45SKEFFwsSbjoMW997Z7c-BmpDR_spuH1gB-piyPh9wuAw09hTSxO6KaXyhn5a334BTkefMxZFx2k75_CBbjD52HlHe3zARPMudCmOmJ-Tp70dMr44nKfk69Xl3cV1tf788eZita6cBA2VaFvXt6K1HVMapW06ROm4dj1vRIlaJ51G0ZRb1UmppNJtuYDGWsG6phGn5MOc95sdzCb50aadidab69Xa-NJtGg0TWi9VUz9A4W9nvkmxTJu3pkzlcBhswDhlo5ta6RqYKvLdfyVwoYEtuZaFvv6L3scplV8tSoJitVa8Lur9rFyKOSfsH9sFZvbbNWW75td2i311yDi1I3aP8vc6C3hzADY7O_TJBufzH1dz0KrZu_PZ_fAD7v5d0axu7-bSPwFPrryr |
CODEN | ARHEAW |
CitedBy_id | crossref_primary_10_3390_life13112131 crossref_primary_10_1016_j_immuni_2015_03_006 crossref_primary_10_1146_annurev_immunol_032414_112227 crossref_primary_10_1007_s00296_018_4092_3 crossref_primary_10_1111_cge_13789 crossref_primary_10_1080_1744666X_2017_1280396 crossref_primary_10_1016_j_berh_2012_07_009 crossref_primary_10_3109_14397595_2013_843755 crossref_primary_10_1007_s10620_019_05525_6 crossref_primary_10_1136_rmdopen_2023_003598 crossref_primary_10_1038_mi_2015_80 crossref_primary_10_1016_j_ejphar_2023_175995 crossref_primary_10_1002_art_30378 crossref_primary_10_1101_cshperspect_a028563 crossref_primary_10_1084_jem_20141091 crossref_primary_10_1016_j_rceng_2016_10_001 crossref_primary_10_3389_fimmu_2017_00043 crossref_primary_10_1073_pnas_1317643111 crossref_primary_10_1016_j_pharmthera_2018_02_011 crossref_primary_10_1186_s12974_022_02425_x crossref_primary_10_1189_jlb_3RU0514_265RR crossref_primary_10_1016_j_clim_2024_110278 crossref_primary_10_1126_scisignal_abg8145 crossref_primary_10_1016_j_rce_2016_08_004 crossref_primary_10_1093_rheumatology_kez294 crossref_primary_10_1155_2024_5573272 crossref_primary_10_1111_imr_12898 crossref_primary_10_1111_febs_16203 crossref_primary_10_1007_s10067_014_2721_0 crossref_primary_10_1007_s12519_019_00294_8 crossref_primary_10_1371_journal_ppat_1003885 crossref_primary_10_3389_fgene_2021_631340 crossref_primary_10_3390_molecules25194572 crossref_primary_10_1007_s12026_012_8272_z crossref_primary_10_1016_j_semarthrit_2019_05_002 crossref_primary_10_1007_s00018_012_0989_2 crossref_primary_10_1016_j_immuni_2012_07_006 crossref_primary_10_1111_jdv_18969 crossref_primary_10_3389_fmed_2023_1257045 crossref_primary_10_1007_s12016_017_8613_8 crossref_primary_10_1186_s43141_021_00268_2 crossref_primary_10_1016_j_clim_2014_07_003 crossref_primary_10_1146_annurev_pathol_012414_040431 crossref_primary_10_1007_s10067_016_3410_y crossref_primary_10_1038_srep10200 crossref_primary_10_5713_ajas_2013_13087 crossref_primary_10_3109_13816810_2012_695421 crossref_primary_10_1007_s00296_018_4002_8 crossref_primary_10_3389_fimmu_2017_00344 crossref_primary_10_1016_j_cytogfr_2016_11_001 crossref_primary_10_1080_14397595_2020_1784542 crossref_primary_10_1002_lio2_28 crossref_primary_10_1016_j_jaip_2023_05_040 crossref_primary_10_1080_10408363_2018_1488805 crossref_primary_10_1097_BOR_0b013e32834dd2d5 crossref_primary_10_1038_ni_3777 crossref_primary_10_2177_jsci_34_329 crossref_primary_10_1371_journal_pgen_1008180 crossref_primary_10_1155_2013_939847 crossref_primary_10_1111_j_1600_065X_2011_01050_x crossref_primary_10_1186_s13256_022_03404_9 crossref_primary_10_1007_s10067_020_05492_8 crossref_primary_10_1073_pnas_1905261116 crossref_primary_10_1042_CS20171498 crossref_primary_10_1097_MIB_0000000000000151 crossref_primary_10_1093_rheumatology_keaa304 crossref_primary_10_3389_fimmu_2021_827815 crossref_primary_10_1186_s12969_022_00669_8 |
Cites_doi | 10.1086/341357 10.1038/sj.cdd.4401734 10.1074/jbc.M502820200 10.1002/art.27326 10.1016/j.cell.2007.07.009 10.1073/pnas.0708616105 10.1038/nm1201-1291 10.1074/jbc.M203915200 10.1146/annurev.immunol.14.1.649 10.1074/jbc.274.48.33835 10.1128/MCB.01468-07 10.1002/art.21618 |
ContentType | Journal Article |
Copyright | Copyright © 2011 by the American College of Rheumatology 2015 INIST-CNRS Copyright © 2011 by the American College of Rheumatology. Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: Copyright © 2011 by the American College of Rheumatology – notice: 2015 INIST-CNRS – notice: Copyright © 2011 by the American College of Rheumatology. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QP 7T5 7TM 7U7 C1K H94 K9. 8FD FR3 P64 RC3 7X8 1XC |
DOI | 10.1002/art.30241 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic Hyper Article en Ligne (HAL) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Toxicology Abstracts Bacteriology Abstracts (Microbiology B) Nucleic Acids Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Environmental Sciences and Pollution Management Genetics Abstracts Engineering Research Database Technology Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Toxicology Abstracts Genetics Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1529-0131 2326-5205 2326-5191 |
EndPage | 1464 |
ExternalDocumentID | oai_HAL_inserm_03889764v1 3277865791 10_1002_art_30241 21538323 24218763 ART30241 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Association François Aupetit – fundername: Agence Nationale pour la Recherche funderid: 06‐MRAR‐010‐02 – fundername: European Union Sixth Framework Programme (EURAMY project grant) funderid: LSHM‐CT‐2006‐037525 – fundername: International Science and Technology Center funderid: A‐1580 |
GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 10A 1CY 1KJ 1L6 1OB 1OC 1ZS 23N 24P 31~ 33P 3O- 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52W 52X 53G 5GY 5RE 66C 6J9 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAHHS AAKAS AANLZ AAQQT AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACFBH ACGFO ACMXC ACPOU ACSCC ACXBN ACXQS ADBTR ADEOM ADIZJ ADMGS ADOZA ADZCM ADZOD AEEZP AEIGN AEIMD AEQDE AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AI. AIACR AITYG AIURR AIWBW AJBDE ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZFZN BDRZF BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J5H JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES M65 MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N4W N9A NNB OIG OK1 OVD P2P P2W P2X P2Z P4B P4D Q11 QB0 QRW RGB RIWAO RJQFR ROL RWI RX1 RXW RYL SAMSI SJN SUPJJ SV3 TAE TEORI TWZ UB1 V2E V8K V9Y VH1 W8V WH7 WIB WIH WIJ WIK WIN WJL WOW WQJ WRC WUP WXI WXSBR X6Y X7M XG1 XPP XV2 YFH YOC ZGI ZXP ZZTAW ~IA ~WT 08R AAUGY AAVGM ABHUG ABPTK ABWRO ACXME ADAWD ADDAD AFVGU AGJLS IQODW ZA5 CGR CUY CVF ECM EIF NPM AAMNL AAYXX ACRPL ACYXJ CITATION 0R~ 3SF 52U 52V 5VS 7QL 7QP 7T5 7TM 7U7 AAESR AASGY ABLJU ABPVW ACGFS ACGOF ACIWK ACPRK ADBBV ADKYN ADXAS ADZMN AENEX AFRAH AHMBA ALAGY AZVAB BFHJK BHBCM BMXJE C1K DIK FUBAC H94 K9. KBYEO NF~ O66 O9- PQQKQ WBKPD WHWMO WOHZO WVDHM 8FD FR3 P64 RC3 7X8 1XC YCJ |
ID | FETCH-LOGICAL-c5181-3bbcfb3bad078e5a6dee5c28cf263a6dbc5c8e360787d557578b63a16aa30d663 |
IEDL.DBID | DR2 |
ISSN | 0004-3591 2326-5191 1529-0131 2326-5205 |
IngestDate | Tue Oct 15 15:45:36 EDT 2024 Tue Dec 03 23:21:19 EST 2024 Wed Dec 04 11:37:41 EST 2024 Thu Oct 10 22:11:44 EDT 2024 Fri Dec 06 01:30:35 EST 2024 Sat Sep 28 08:00:44 EDT 2024 Sun Oct 22 16:05:28 EDT 2023 Sat Aug 24 00:54:14 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Relapse Missense mutation Diseases of the osteoarticular system Familial mediterranean fever Rheumatology Hereditary periodic fever Identification Genetic disease Inflammatory disease |
Language | English |
License | CC BY 4.0 Copyright © 2011 by the American College of Rheumatology. http://onlinelibrary.wiley.com/termsAndConditions#vor Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5181-3bbcfb3bad078e5a6dee5c28cf263a6dbc5c8e360787d557578b63a16aa30d663 |
Notes | Dr. Grateau has received honoraria from Novartis (less than $10,000). ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ORCID | 0000-0001-9506-3968 |
PMID | 21538323 |
PQID | 1517048724 |
PQPubID | 946334 |
PageCount | 6 |
ParticipantIDs | hal_primary_oai_HAL_inserm_03889764v1 proquest_miscellaneous_864784107 proquest_miscellaneous_1238109285 proquest_journals_1517048724 crossref_primary_10_1002_art_30241 pubmed_primary_21538323 pascalfrancis_primary_24218763 wiley_primary_10_1002_art_30241_ART30241 |
PublicationCentury | 2000 |
PublicationDate | May 2011 |
PublicationDateYYYYMMDD | 2011-05-01 |
PublicationDate_xml | – month: 05 year: 2011 text: May 2011 |
PublicationDecade | 2010 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: Hoboken , NJ – name: United States – name: Atlanta |
PublicationTitle | Arthritis & rheumatology (Hoboken, N.J.) |
PublicationTitleAlternate | Arthritis Rheum |
PublicationYear | 2011 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley Wiley Subscription Services, Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley – name: Wiley Subscription Services, Inc |
References | 2005; 280 2009; 68 2001; 7 2006; 13 2006; 54 2007; 130 2002; 277 2008; 28 1999; 274 2008; 105 2002; 71 1996; 14 2010; 62 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_11_2 e_1_2_7_10_2 Gattorno M (e_1_2_7_14_2) 2009; 68 |
References_xml | – volume: 105 start-page: 1614 year: 2008 end-page: 9 article-title: Mutations in NALP12 cause hereditary periodic fever syndromes publication-title: Proc Natl Acad Sci U S A – volume: 28 start-page: 1841 year: 2008 end-page: 50 article-title: ATP binding by Monarch‐1/NLRP12 is critical for its inhibitory function publication-title: Mol Cell Biol – volume: 62 start-page: 1176 year: 2010 end-page: 85 article-title: Functional consequences of a germline mutation in the leucine‐rich repeat domain of NLRP3 identified in an atypical autoinflammatory disorder publication-title: Arthritis Rheum – volume: 13 start-page: 236 year: 2006 end-page: 49 article-title: Cryopyrin and pyrin activate caspase‐1, but not NF‐κB, via ASC oligomerization publication-title: Cell Death Differ – volume: 68 start-page: 83 issue: Suppl 13 year: 2009 article-title: Clinical and immunological characterization of an Italian family with a novel NALP12 mutation publication-title: Ann Rheum Dis – volume: 7 start-page: 1291 year: 2001 end-page: 7 article-title: Possible new role for NF‐βB in the resolution of inflammation publication-title: Nat Med – volume: 71 start-page: 198 year: 2002 end-page: 203 article-title: Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes publication-title: Am J Hum Genet – volume: 274 start-page: 33835 year: 1999 end-page: 8 article-title: ASC, a novel 22‐kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL‐60 cells publication-title: J Biol Chem – volume: 14 start-page: 649 year: 1996 end-page: 83 article-title: The NF‐κB and IκB proteins: new discoveries and insights publication-title: Annu Rev Immunol – volume: 130 start-page: 918 year: 2007 end-page: 31 article-title: NF‐κB is a negative regulator of IL‐1β secretion as revealed by genetic and pharmacological inhibition of IKKβ publication-title: Cell – volume: 280 start-page: 39914 year: 2005 end-page: 24 article-title: The CATERPILLER protein Monarch‐1 is an antagonist of Toll‐like receptor‐, tumor necrosis factor α‐, and Mycobacterium tuberculosis‐induced pro‐inflammatory signals publication-title: J Biol Chem – volume: 54 start-page: 508 year: 2006 end-page: 14 article-title: PYPAF1 nonsense mutation in a patient with an unusual autoinflammatory syndrome: role of PYPAF1 in inflammation publication-title: Arthritis Rheum – volume: 277 start-page: 29874 year: 2002 end-page: 80 article-title: PYPAF7, a novel PYRIN‐containing Apaf1‐like protein that regulates activation of NF‐κB and caspase‐1‐dependent cytokine processing publication-title: J Biol Chem – ident: e_1_2_7_6_2 doi: 10.1086/341357 – ident: e_1_2_7_7_2 doi: 10.1038/sj.cdd.4401734 – volume: 68 start-page: 83 issue: 13 year: 2009 ident: e_1_2_7_14_2 article-title: Clinical and immunological characterization of an Italian family with a novel NALP12 mutation publication-title: Ann Rheum Dis contributor: fullname: Gattorno M – ident: e_1_2_7_4_2 doi: 10.1074/jbc.M502820200 – ident: e_1_2_7_8_2 doi: 10.1002/art.27326 – ident: e_1_2_7_11_2 doi: 10.1016/j.cell.2007.07.009 – ident: e_1_2_7_2_2 doi: 10.1073/pnas.0708616105 – ident: e_1_2_7_12_2 doi: 10.1038/nm1201-1291 – ident: e_1_2_7_3_2 doi: 10.1074/jbc.M203915200 – ident: e_1_2_7_10_2 doi: 10.1146/annurev.immunol.14.1.649 – ident: e_1_2_7_5_2 doi: 10.1074/jbc.274.48.33835 – ident: e_1_2_7_9_2 doi: 10.1128/MCB.01468-07 – ident: e_1_2_7_13_2 doi: 10.1002/art.21618 |
SSID | ssj0002353 ssj0000970605 |
Score | 2.3763335 |
Snippet | Objective
To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a... To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a nonsense and a... Objective To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a... OBJECTIVETo gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a... Objective: To gain insight into the molecular bases of genetically unexplained periodic fever syndromes (PFS) by screening NLRP12, a gene in which only a... |
SourceID | hal proquest crossref pubmed pascalfrancis wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1459 |
SubjectTerms | Apoptosis Binding sites Biological and medical sciences Caspase-1 CpG islands Diseases of the osteoarticular system Exons Fever Genetics Haplotypes Hereditary Autoinflammatory Diseases - genetics Human genetics Humans Inflammatory joint diseases Intracellular Signaling Peptides and Proteins - genetics Life Sciences Malformations and congenital and or hereditary diseases involving bones. Joint deformations Medical sciences Missense mutation Mutation Mutation, Missense - genetics Phenotype Speck |
Title | Identification and functional consequences of a recurrent NLRP12 missense mutation in periodic fever syndromes |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fart.30241 https://www.ncbi.nlm.nih.gov/pubmed/21538323 https://www.proquest.com/docview/1517048724 https://search.proquest.com/docview/1238109285 https://search.proquest.com/docview/864784107 https://inserm.hal.science/inserm-03889764 |
Volume | 63 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qH0QQrd_R9lhFwZdck91sPvCptJZT2yLFQh-EsJ9Y5HLlPnzwr3cmm-Q8sSC-3bETlp2dyfx2duYXgNc-S6w2uY4LpXWc-dTGynAfm0Qa6vw0vqR-59OzfHKRfbyUl1vwru-FCfwQQ8KNPKN9X5ODK73YX5OGombHAiMMHX1SUVA539H5mjqKi46BkjL_skp7VqGE7w9PbsSiW9-oEvLutVqgcnz4qsXfYOcmim3D0PF9-NovIFSffB-vlnpsfv7B7fifK9yBex08ZQfBnh7Almsewu3T7gL-ETShsdd3mT6mGssoNIaMIjO_1WazmWeKzSmfTwxQ7Ozk_HPK2ZQKAFCKTVehCoBdNYzolmc4B_MOXYv1NAqLx3Bx_P7L4STuPtkQG4lYIRZaG6-FVhahh5Mqt85Jw0vjeS7wnzbSlE7kOFpYKYlMX-NAmislEovo5wlsN7PGPQNmi7wyrkhtRS0sSlaitCkalleeey91BK_6zauvAzNHHTiYeY2aq1vNRfAGt3UYJy7tycFJfYXLnE9rYsJBOJb9QLnRxsYPT9CNOZH2RbDbW0LdefmiRrRU4Buw4FkEL4dh1CNduqjGzVYoQ5goqXgpI2A3yJTU8JvhQTyCp8HI1vNTRBIc53_bmsrNS63xANT-eP7voi_gTsiRUwHnLmwv5yu3hyBrqUfoTR8-jVqf-gWf5STl |
link.rule.ids | 230,314,780,784,885,1375,27924,27925,46294,46718 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3ra9RAEB9qBRXE9yNa6yoKfsk12WTzAL8UtZx6d0hpoV9k2ScWuVy5hx_8653JJneeWBC_3bETlp2dyfx2duYXgFc-T6w2hY5LpXWc-9TGynAfm0QY6vw0vqJ-5_GkGJ7mn87E2Q687XthAj_EOuFGntG-r8nBKSF9sGENRdUOMgwxePa5iu6eUkHX--MNeRTPOg5Kyv2LOu15hRJ-sH50Kxpd-Ua1kDcv1ALV48N3Lf4GPLdxbBuIjm7D134Jof7k-2C11APz8w92x_9d4x241SFUdhhM6i7suOYeXBt3d_D3oQm9vb5L9jHVWEbRMSQVmfmtPJvNPFNsTil9IoFik9Hxl5SzKdUAoBSbrkIhADtvGDEuz3AO5h16F-uZFBYP4PTow8m7Ydx9tSE2AuFCnGltvM60sog-nFCFdU4YXhnPiwz_aSNM5bICR0srBPHpaxxIC6WyxCIAegi7zaxxj4HZsqiNK1NbUxeLEnVW2RRtyyvPvRc6gpf97smLQM4hAw0zl6g52Wougte4r-txotMeHo7kOS5zPpVEhoOILP-BcvtbO79-gi7Nibcvgr3eFGTn6AuJgKnEl2DJ8wherIdRj3Tvoho3W6EMwaKk5pWIgF0iU1HPb45n8QgeBSvbzE9BKeM4_5vWVi5fqsQzUPvjyb-LPofrw5PxSI4-Tj4_hRshZU71nHuwu5yv3DPEXEu937rWL_guKA0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9qhSKI39Voraso-JJrssnmA5-K9Tj1epRioQ9C2E8scrnjPnzwr3cmm-Q8sSC-3bETlp2dyfx2duYXgNcujYzSmQpzqVSYutiEUnMX6kho6vzUrqB-59NJNrpIP12Kyx141_XCeH6IPuFGntG8r8nB58YdbUhDUbODBCMMHn1uphkviTj_5HzDHcWTloKSUv-ijDtaoYgf9Y9uBaMb36gU8vZcLlE7zn_W4m-4cxvGNnFoeBe-divw5SffB-uVGuiff5A7_ucS78GdFp-yY29Q92HH1g9g77S9gX8Ite_sdW2qj8naMIqNPqXI9G_F2WzmmGQLSugTBRSbjM_PYs6mVAGAUmy69mUA7KpmxLc8wzmYs-hbrONRWD6Ci-GHL-9HYfvNhlALBAthopR2KlHSIPawQmbGWqF5oR3PEvyntNCFTTIczY0QxKavcCDOpEwig_BnH3brWW2fADN5Vmqbx6akHhYpyqQwMVqWk447J1QAr7rNq-aemqPyJMy8Qs1VjeYCeIPb2o8TmfboeFxd4TIX04qocBCPpT9Q7nBr4_sn6MqcWPsCOOgsoWrdfFkhXMrxFZjzNICX_TDqkW5dZG1na5QhUBSVvBABsGtkCur4TfEkHsBjb2Sb-SkkJRznf9uYyvVLrfAE1Px4-u-iL2Dv7GRYjT9OPj-DWz5fTsWcB7C7WqztcwRcK3XYONYvaMomvA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Identification+and+functional+consequences+of+a+recurrent+NLRP12+missense+mutation+in+periodic+fever+syndromes&rft.jtitle=Arthritis+and+rheumatism&rft.au=J%C3%A9ru%2C+Isabelle&rft.au=Le+Borgne%2C+Ga%C3%ABlle&rft.au=Cochet%2C+Emmanuelle&rft.au=Hayrapetyan%2C+Hasmik&rft.date=2011-05-01&rft.issn=0004-3591&rft.eissn=1529-0131&rft.volume=63&rft.issue=5&rft.spage=1459&rft.epage=1464&rft_id=info:doi/10.1002%2Fart.30241&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_art_30241 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0004-3591&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0004-3591&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0004-3591&client=summon |